1. Medtech Insight
  2. >>Device Area

SCAI2018: New Study Shows 3D Printing Helps Prevent Leaks In Heart-Valve Patients

 
• By Marion Webb

The clinical use of 3D printing got a boost when interventional cardiologists presented data at the annual meeting of The Society for Cardiovascular Angiography and Interventions that supported th4 technology's effectiveness in helping to predict paravalvular leak in patients undergoing transcatheter aortic valve replacement. The implantation of an ill-fitting valve that can lead to paravalvular leak is a common risk of TAVR procedures.

Two female hands holding a 3d printed human heart

Data from a new study that evaluated the effectiveness of 3D printing and computer modeling in predicting paravalvular leak (PVL) in patients undergoing transcatheter aortic valve replacement (TAVR) has backed the use of the technology for addressing the problem of ill-fitting valves. The data was presented on April 26 at the 41st annual Society for Cardiovascular Angiography and Interventions (SCAI) meeting, which is being held in San Diego through April 28. 

In the study, six patients undergoing TAVR for severe calcific aortic stenosis and at risk for PVL had pre-procedure computed...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Cardiology

More from Device Area

Deaths And Serious Injuries Linked To A Pair Of Heart Device Recalls

 
• By Brian Bossetta

Two recent recalls from the US FDA involve three deaths linked to an issue with an Abiomed heart pump — as well as three serious injuries related to angiographic catheters from Cook Medical.

‘Be Quick, But Don’t Hurry’: Dexcom CEO Talks CGM Market Success

 
• By Marion Webb

Dexcom’s CEO Kevin Sayer discusses this fall’s planned launch of the 15-day G7 CGM, downplays Abbott’s dual-sensor while focusing on development of multi-analyte G8, making OTC Stelo app more “consumerish” for Europeans, and more.

New Draft Guidance Clarifies FDA’s UDI Rules For Combination Products

 
• By Elizabeth Orr

The FDA has released draft guidance clarifying UDI rules for drug- and device-led combination products. The document specifies labeling requirements and makes recommendations to reduce confusion between UDIs and NDCs. Comments are being accepted until Sept. 24.